Cytomegalovirus (CMV) infections in children undergoing hematopoetic stem cell transplantation

Pediatric Hematology and Oncology

Volumn 22, Issue 4, 2005, Pages 271-276

  Zaucha Prazmo, Agnieszka ^a,b   Wójcik, Beata ^a   Drabko, Katarzyna ^a   Choma, Marta ^a   Kowalczyk, Jerzy R ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Children University Hospital   (Poland)

Author keywords

Children; Cytomegalovirus; Hematopoetic stem cell transplantation

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GANCICLOVIR; VIRUS ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ANTIGEN DETECTION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; LEUKOCYTE; RISK FACTOR; SEROLOGY; VIRUS REACTIVATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LEUKOCYTES; RISK FACTORS;

EID: 20044379755     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010590935158     Document Type: Article

References (10)

1. Hebart H, Wuchter P, Loeffler J, et al. Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant. Bone Marrow Transplant. 2001;28:213-218.
2. Zaia JA. Prevention and management of CMV-related problems after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:633-638.
3. Górski P, Sawiński K, Hansz J. Diagnostyka, profilaktyka i terapia infekcji wywołanych cytomegalowirusem u chorych leczonych przeszczepianiem szpiku. Acta Hematol. Pol. 1995;26:153-161.
4. Monthy M, Faucher C, Vey N, et al. High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation. Bone Marrow Transplant. 2000;26:251-255.
5. Gor D, Sabin C, Prentice HG. et al. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GvHD and CMV disease. Bone Marrow Transplant. 1998;21:597-605.
6. Nakamura R, Cortez K, solomon S, et al. High-dose acyclovir and pre-emptive gancyclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant. 2002;30:235-243.
7. Grob JB, Grundy JE, Prentice HG, et al. Immune donors can protect marrow transplant recipients from severe cytomegalovirus infections. Lancet. 1987;774-776.
8. Holmberg LA, Boeckh M, Hooper H, et al. Increased incident of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood. 1999;94:4029-4035.
9. Riddel SR, Walter BA, Gilbert MJ, Greenberg PD. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones. Bone Marrow Transplant. 1994;14(suppl):78-84.
10. Okumura H, Yoshida T, Takamatsu H, et al. CD8-depleted donor leukocyte transfusions for cytomegalovirus antigenaemia in patient with acute lymphoblastic leukemia treated with allogeneic CD34+ cell transplantation. Am J Hematol. 2000;655:278-280.